BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35194732)

  • 1. Apigenin inhibits growth of melanoma by suppressing miR-512-3p and promoting the G1 phase of cell cycle involving the p27 Kip1 protein.
    Xie Q; Zhang R; Liu D; Yang J; Hu Q; Shan C; Li X
    Mol Cell Biochem; 2022 May; 477(5):1569-1582. PubMed ID: 35194732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of miRNA-106b inhibits growth of melanoma cells by promoting G1-phase cell cycle arrest and reactivation of p21/WAF1/Cip1 protein.
    Prasad R; Katiyar SK
    Oncotarget; 2014 Nov; 5(21):10636-49. PubMed ID: 25361006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-196a-mediated downregulation of p27
    Zhan B; Huang L; Chen Y; Ye W; Li J; Chen J; Yang S; Jiang W
    Prostate; 2020 Sep; 80(12):1024-1037. PubMed ID: 32628792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation.
    Albino AP; Juan G; Traganos F; Reinhart L; Connolly J; Rose DP; Darzynkiewicz Z
    Cancer Res; 2000 Aug; 60(15):4139-45. PubMed ID: 10945621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-196a is upregulated in gastric cancer and promotes cell proliferation by downregulating p27(kip1).
    Sun M; Liu XH; Li JH; Yang JS; Zhang EB; Yin DD; Liu ZL; Zhou J; Ding Y; Li SQ; Wang ZX; Cao XF; De W
    Mol Cancer Ther; 2012 Apr; 11(4):842-52. PubMed ID: 22343731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erlotinib, an effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 up-regulation and nuclear translocation in association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines.
    Ling YH; Li T; Yuan Z; Haigentz M; Weber TK; Perez-Soler R
    Mol Pharmacol; 2007 Aug; 72(2):248-58. PubMed ID: 17456787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β1 stimulates human Tenon's capsule fibroblast proliferation by miR-200b and its targeting of p27/kip1 and RND3.
    Tong J; Fu Y; Xu X; Fan S; Sun H; Liang Y; Xu K; Yuan Z; Ge Y
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2747-56. PubMed ID: 24667864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpressed Hsa_circ_0001326 Contributes to the Decreased Cell Viability in SWAN71 Cells by Regulating MiR-186-5p/p27 Kip1 Axis.
    Tan J; Zhong Z; Xu W; Zhang N
    Biol Pharm Bull; 2021; 44(4):507-514. PubMed ID: 33790102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Up-regulation of p27(kip1) by miR-221/222 antisense oligonucleotides enhances the radiosensitivity of U251 glioblastoma].
    Zhang C; Wang G; Kang C; Du Y; Pu P
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Dec; 26(6):634-8. PubMed ID: 19953484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells.
    Bhatt KV; Hu R; Spofford LS; Aplin AE
    Oncogene; 2007 Feb; 26(7):1056-66. PubMed ID: 16924241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-152-3p promotes the development of chronic myeloid leukemia by inhibiting p27.
    Wang L; Wang Y; Lin J
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8789-8796. PubMed ID: 30575920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
    Li A; Wang J; Wu M; Zhang X; Zhang H
    Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-200b stimulates tumour growth in TGFBR2-null colorectal cancers by negatively regulating p27/kip1.
    Fu Y; Liu X; Zhou N; Du L; Sun Y; Zhang X; Ge Y
    J Cell Physiol; 2014 Jun; 229(6):772-82. PubMed ID: 24151081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of miR-221 and its inverse correlation with p27Kip¹ in hepatocellular carcinoma.
    Fu X; Wang Q; Chen J; Huang X; Chen X; Cao L; Tan H; Li W; Zhang L; Bi J; Su Q; Chen L
    Mol Biol Rep; 2011 Jun; 38(5):3029-35. PubMed ID: 20146005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-222 confers the resistance of breast cancer cells to Adriamycin through suppression of p27(kip1) expression.
    Wang DD; Li J; Sha HH; Chen X; Yang SJ; Shen HY; Zhong SL; Zhao JH; Tang JH
    Gene; 2016 Sep; 590(1):44-50. PubMed ID: 27282281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-Regulation of CK2α Leads toUp-Regulation of the Cyclin-Dependent Kinase Inhibitor p27
    Guerra B; Dembic M; Siddiqui MA; Dominguez I; Ceppi P; Andresen BS
    Cell Physiol Biochem; 2020 Nov; 54(6):1177-1198. PubMed ID: 33216476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropilin-2 Inhibits Drug Resistance and Progression of Melanoma Involving the MiR-331-3p Regulated Cascade.
    Xie Q; Zhang R; Liu D; Yang J; Hu Q; Shan C; Li X
    Curr Mol Pharmacol; 2023; 16(7):787-799. PubMed ID: 36545728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NADPH oxidase 5 (NOX5)-induced reactive oxygen signaling modulates normoxic HIF-1α and p27
    Antony S; Jiang G; Wu Y; Meitzler JL; Makhlouf HR; Haines DC; Butcher D; Hoon DS; Ji J; Zhang Y; Juhasz A; Lu J; Liu H; Dahan I; Konate M; Roy KK; Doroshow JH
    Mol Carcinog; 2017 Dec; 56(12):2643-2662. PubMed ID: 28762556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of miR-221 and -222 in response to increased extracellular signal-regulated kinases 1/2 activity exacerbates neointimal hyperplasia in diabetes mellitus.
    Lightell DJ; Moss SC; Woods TC
    Atherosclerosis; 2018 Feb; 269():71-78. PubMed ID: 29276985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix.
    Inamoto T; Yamochi T; Ohnuma K; Iwata S; Kina S; Inamoto S; Tachibana M; Katsuoka Y; Dang NH; Morimoto C
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3470-7. PubMed ID: 16740772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.